首灃控股(01703.HK)中期虧損擴大約49.3%至4250萬港元
格隆匯11月25日丨首灃控股(01703.HK)發佈中期業績,截至2019年9月30日止6個月,公司實現收入達3.322億港元,同比減少約0.3%;期內虧損及全面開支總額為約4250萬港元,同比擴大約49.3%;每股虧損為約4.3港仙;不派息。
公告表示,報告期內,收益減少主要由於可比酒樓的銷售收益減少約9.2%,迥異於公司過往的趨勢(即可比酒樓銷售額於前三個財政年度以介乎1.1%至4.6%的幅度減少),主要由於集團酒樓所在的若干商場及商業大樓臨時更改或縮短營業時間所致;及兩間酒樓在2019年上半年的2019年7月及9月開業導致收益增加,其部分抵銷上述的收益減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.